Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Healthstream (HSTM) Shares Outstanding (Weighted Average) (2016 - 2026)

Healthstream has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $30.0 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 1.21% to $30.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.0 million through Dec 2025, down 1.21% year-over-year, with the annual reading at $30.0 million for FY2025, 1.21% down from the prior year.
  • Shares Outstanding (Weighted Average) was $30.0 million for Q4 2025 at Healthstream, up from $29.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $31.5 million in Q3 2021 and troughed at $29.7 million in Q3 2025.
  • The 5-year median for Shares Outstanding (Weighted Average) is $30.6 million (2023), against an average of $30.7 million.
  • Year-over-year, Shares Outstanding (Weighted Average) dropped 3.29% in 2022 and then rose 0.48% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $31.5 million in 2021, then dropped by 2.81% to $30.6 million in 2022, then decreased by 0.25% to $30.6 million in 2023, then fell by 0.61% to $30.4 million in 2024, then fell by 1.21% to $30.0 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Shares Outstanding (Weighted Average) are $30.0 million (Q4 2025), $29.7 million (Q3 2025), and $30.4 million (Q2 2025).